Return to content in this issue


Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies

Jesenak M1, Brndiarova M1, Banovcin P1, Varga L2, Farkas H2

1National Center for Hereditary Angioedema, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital, Martin, Slovakia
2Hungarian Angioedema Center of Excellence and Reference, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary

J Investig Allergol Clin Immunol 2021; Vol. 31(3)
doi: 10.18176/jiaci.0635

Key words: Acquired angioedema, Anti-C1-INH autoantibodies, Recombinant human C1- inhibitor